Munich, Germany, April 23, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company developing small molecule medicines for inflammatory and ...
Thursday, April 23, 2026 at 10 a.m. ET. Call participants. Chairman, President, and Chief Executive Officer — Keith A. Harvey ...
Teck Resources Limited (Teck) today announced its unaudited first quarter results for 2026. "We delivered a very strong start ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results